Related Experiment Video

Updated: Jan 18, 2026

Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

1.0K

Uncommon Presentation of Subacute Sclerosing Panencephalitis: Two Cases of Rapidly Progressive Parkinsonism

Derencan Ateş1, Bedia Samanci1, Gözde Baran2

  • 1Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Journal of Movement Disorders
|September 11, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.2K
Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
08:33

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Published on: February 28, 2016

13.8K

Related Experiment Videos

Last Updated: Jan 18, 2026

Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

1.0K
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.2K
Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
08:33

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Published on: February 28, 2016

13.8K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

995
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
995
Neural Regulation01:37

Neural Regulation

43.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.2K

Articles linked to this work by shared authors, journal, and citation graph.

ADHD symptom positivity and its association with medication adherence and psychiatric burden in adults with epilepsy.

Epilepsy & behavior : E&B·2026

Clinical and Electrodiagnostic Characteristics of COVID-19-Associated Guillain-Barré Syndrome: A Multicenter Study.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026

Photosensitive absence seizures: a rare endophenotype with clinical and prognostic implications.

Seizure·2026

SLC7A6OS Founder Mutation: A Rare Cause of Progressive Myoclonus Epilepsy Dated to 1100 Years Ago.

Movement disorders : official journal of the Movement Disorder Society·2026

Expanding the adult spectrum of TUBB4A disease: a spasticity-tremor phenotype with network imaging correlates.

Neurogenetics·2026

The effect of epilepsy education on the knowledge and attitudes of nurses and technicians in a neurology clinic: A longitudinal study.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026

Establishment of Standardized Normative Reference Values for Pressure-Based Gait Analysis in the Healthy Korean Population: A Nationwide Multi-Center Registry Study.

Journal of movement disorders·2026

Altered Fixation-Related Eye-Movement Dynamics in Cervical Dystonia.

Journal of movement disorders·2026

Development and Validation of the 9-item Parkinson's Disease Screening Questionnaire.

Journal of movement disorders·2026

Candidate neurobiological pathways linking physical exercise to cognition in Parkinson's disease: a hypothesis-generating translational framework.

Journal of movement disorders·2026

Targeting the Gut to Modify Parkinson's Disease: From Mechanisms to Potential Therapeutics.

Journal of movement disorders·2026

Home-based visual perceptual learning improves contrast sensitivity in Parkinson's disease: a proof-of-concept study.

Journal of movement disorders·2026

Astrocyte Orai1 signaling promotes spinal excitatory synaptic potentiation and neuropathic pain after nerve injury in male mice.

Pain·2026

Baseline Wearable Turning-Derived Signature and Dopamine Transporter-Derived Measures in Relation to Subsequent Motor Progression in Parkinson's Disease: An Exploratory Longitudinal Study.

Sensors (Basel, Switzerland)·2026

Reliability of Myotonometric Measurements and Their Associations with Motor Performance in Parkinson's Disease.

Sensors (Basel, Switzerland)·2026

Naringin Attenuates Diabetic Neuropathic Pain and Modulates TRPV1-Related Ca2+ Dysregulation and MAPK/NF-ΚB Signaling.

Pharmaceuticals (Basel, Switzerland)·2026

Kidney Involvement in Primary Sjögren Syndrome: Focus on Tubulointerstitial Nephritis.

Medicina (Kaunas, Lithuania)·2026

Low-Dose Naltrexone for Neuropathic Pain: Mechanistic Plausibility, Phenotype Transferability, and the Limits of Current Clinical Evidence.

Life (Basel, Switzerland)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us